Does dimerisation dominate for a GLP-1 receptor agonist held at 25 °C?

Asked 22 Jul 2024Modified 2.0 years agoViewed 12k times

Stated plainly: dimerisation · a GLP-1 receptor agonist · 25 °C.

The empirical answer seems settled. The explanation does not.

If the honest answer is that nobody knows, I would rather hear that than a plausible story.

What is the causal chain, and where does it stop being established?

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

832 questionsstorage

storage

Storage conditions and their evidence base: minus twenty degrees for powder, refrigerated for solution, protection from light, and what the…

646 questionshplc

hplc

Reverse-phase high-performance liquid chromatography, the workhorse purity method. Column chemistry, mobile-phase choice, gradient slope,…

466 questions

shareeditfollowflag

askedn_takahashi36k3822 Jul 2024

8Have you seen anything published on this, or is it inference from the mechanism? – petra_hovland 2 months ago

Useful. I have added the accept threshold suggestion to my own notes. – RP_C18 4 months ago

add a comment

No answers yet

This question has not been answered. It has been viewed 12k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.

Linked questions

24 What does a 96.8% purity with a method section attached let me conclude?13 Does aggregation dominate for cagrilintide held at 37 °C?36 Does fibrillation produce a resolvable peak on a wide-pore C18 column, or does it co-elute?21 Is 97.1% a realistic purity ceiling for ecnoglutide given its chain length?

PeptideMeter

Published, aggregated third-party test data and vendor ratings. Stated methodology.

Browse results

Hot on the stack

Why does oxidation accelerate at 37 °C rather than proceeding linearly?31 votes · 5 answers · 46k views How many units on a 1 mL luer-lock syringe is a 5 mg dose at 8 mg/mL?17 votes · 5 answers · 45k views Why did my albumin-to-creatinine ratio move after sixteen weeks on tirzepatide?41 votes · 5 answers · 44k views Is ecnoglutide at 2 mg/mL stable enough for ten weeks of multi-withdrawal use?31 votes · 5 answers · 43k views Does constipation at week ten of semaglutide usually resolve without a dose change?40 votes · 5 answers · 49k views Is SSA worth the price difference against Hunan Aslsen Technology on measured results?39 votes · 0 answers · 48k views How do I compare MKM and CPC on lead time to Spain?30 votes · 5 answers · 47k views

The stack

Questions5.2k

Answers20k

Accepted3.1k

Unanswered741

Tags107

Users220

Vendors tracked20

Does dimerisation dominate for a GLP-1 receptor agonist held at 25 °C?

peptide-stability

storage

hplc

No answers yet

PeptideMeter - Independent Peptide Analytics

Your answer

Browse

About